Literature DB >> 35031697

Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation.

Julian Schwärzler1, Lisa Mayr1, Susanne Kaser1, Timon E Adolph2, Bernhard Radlinger1, Felix Grabherr1, Maureen Philipp1, Bernhard Texler1, Christoph Grander1, Andreas Ritsch1, Monika Hunjadi1, Barbara Enrich1, Karin Salzmann1, Qitao Ran3, Lukas A Huber4, Herbert Tilg1.   

Abstract

OBJECTIVES: Metabolic inflammation is a hallmark of obesity and related disorders, afflicting substantial morbidity and mortality to individuals worldwide. White visceral and subcutaneous adipose tissue not only serves as energy storage but also controls metabolism. Adipose tissue inflammation, commonly observed in human obesity, is considered a critical driver of metabolic perturbation while molecular hubs are poorly explored. Metabolic stress evoked by e.g. long-chain fatty acids leads to oxidative perturbation of adipocytes and production of inflammatory cytokines, fuelling macrophage infiltration and systemic low-grade inflammation. Glutathione peroxidase 4 (GPX4) protects against lipid peroxidation, accumulation of oxygen-specific epitopes and cell death, collectively referred to as ferroptosis. Here, we explore the function of adipocyte GPX4 in mammalian metabolism.
METHODS: We studied the regulation and function of GPX4 in differentiated mouse adipocytes derived from 3T3-L1 fibroblasts. We generated two conditional adipocyte-specific Gpx4 knockout mice by crossing Gpx4fl/fl mice with Adipoq-Cre+ (Gpx4-/-AT) or Fabp4-Cre+ (Gpx4+/-Fabp4) mice. Both models were metabolically characterized by a glucose tolerance test and insulin resistance test, and adipose tissue lipid peroxidation, inflammation and cell death were assessed by quantifying oxygen-specific epitopes, transcriptional analysis of chemokines, quantification of F4/80+ macrophages and TUNEL labelling.
RESULTS: GPX4 expression was induced during and required for adipocyte differentiation. In mature adipocytes, impaired GPX4 activity spontaneously evoked lipid peroxidation and expression of inflammatory cytokines such as TNF-α, interleukin 1β (IL-1β), IL-6 and the IL-8 homologue CXCL1. Gpx4-/-AT mice spontaneously displayed adipocyte hypertrophy on a chow diet, which was paralleled by the accumulation of oxygen-specific epitopes and macrophage infiltration in adipose tissue. Furthermore, Gpx4-/-AT mice spontaneously developed glucose intolerance, hepatic insulin resistance and systemic low-grade inflammation, when compared to wildtype littermates, which was similarly recapitulated in Gpx4+/-Fabp4 mice. Gpx4-/-AT mice exhibited no signs of adipocyte death.
CONCLUSION: Adipocyte GPX4 protects against spontaneous metabolic dysregulation and systemic low-grade inflammation independent from ferroptosis, which could be therapeutically exploited in the future.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35031697     DOI: 10.1038/s41366-022-01064-9

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  57 in total

Review 1.  Adapting to obesity with adipose tissue inflammation.

Authors:  Shannon M Reilly; Alan R Saltiel
Journal:  Nat Rev Endocrinol       Date:  2017-08-11       Impact factor: 43.330

Review 2.  Mechanisms, Pathophysiology, and Management of Obesity.

Authors:  Steven B Heymsfield; Thomas A Wadden
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

Review 3.  Inflammation, metaflammation and immunometabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2017-02-08       Impact factor: 49.962

4.  Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.

Authors:  Caroline E Dale; Ghazaleh Fatemifar; Tom M Palmer; Jon White; David Prieto-Merino; Delilah Zabaneh; Jorgen E L Engmann; Tina Shah; Andrew Wong; Helen R Warren; Stela McLachlan; Stella Trompet; Max Moldovan; Richard W Morris; Reecha Sofat; Meena Kumari; Elina Hyppönen; Barbara J Jefferis; Tom R Gaunt; Yoav Ben-Shlomo; Ang Zhou; Aleksandra Gentry-Maharaj; Andy Ryan; Renée de Mutsert; Raymond Noordam; Mark J Caulfield; J Wouter Jukema; Bradford B Worrall; Patricia B Munroe; Usha Menon; Chris Power; Diana Kuh; Debbie A Lawlor; Steve E Humphries; Dennis O Mook-Kanamori; Naveed Sattar; Mika Kivimaki; Jacqueline F Price; George Davey Smith; Frank Dudbridge; Aroon D Hingorani; Michael V Holmes; Juan P Casas
Journal:  Circulation       Date:  2017-05-12       Impact factor: 29.690

Review 5.  Anatomical, Physiological, and Functional Diversity of Adipose Tissue.

Authors:  Rachel K Zwick; Christian F Guerrero-Juarez; Valerie Horsley; Maksim V Plikus
Journal:  Cell Metab       Date:  2018-01-09       Impact factor: 27.287

Review 6.  Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.

Authors:  G A Bray; K K Kim; J P H Wilding
Journal:  Obes Rev       Date:  2017-05-10       Impact factor: 9.213

Review 7.  Leptin and the endocrine control of energy balance.

Authors:  Jeffrey M Friedman
Journal:  Nat Metab       Date:  2019-08-12

Review 8.  The intestinal microbiota fuelling metabolic inflammation.

Authors:  Herbert Tilg; Niv Zmora; Timon E Adolph; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2019-08-06       Impact factor: 53.106

Review 9.  Metabolic Messengers: Adiponectin.

Authors:  Leon G Straub; Philipp E Scherer
Journal:  Nat Metab       Date:  2019-03-14

10.  High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity.

Authors:  Masayuki Saito; Yuko Okamatsu-Ogura; Mami Matsushita; Kumiko Watanabe; Takeshi Yoneshiro; Junko Nio-Kobayashi; Toshihiko Iwanaga; Masao Miyagawa; Toshimitsu Kameya; Kunihiro Nakada; Yuko Kawai; Masayuki Tsujisaki
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.